As circulating leptin levels are dramatically reduced during MD, we hypothesized that exogenous leptin treatment would normalize at least some of the long-term effects on the hippocampus and cerebral cortex, as well as some of the behavioral alterations seen in adult MD rats. This evidence concerns the gene LEP and Menkes disease.